Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
01/2007
01/09/2007CA2344248C 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
01/09/2007CA2223011C Oxazolidinone derivatives, their preparation and therapeutical use
01/09/2007CA2174797C Cyanobenzenesulfenyl halide and process for preparation of 3-substituted benzisothiazole using the same
01/09/2007CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
01/04/2007WO2007002637A1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
01/04/2007WO2007002584A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
01/04/2007WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/04/2007WO2007002461A1 3,4-substituted thiazoles as ampk activators
01/04/2007WO2007002181A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
01/04/2007WO2007000582A1 Heterocyclic non-peptide gnrh antagonists
01/04/2007WO2007000432A1 Oxazolidinone derivatives and use thereof as antibiotics
01/04/2007WO2007000248A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
01/04/2007WO2007000246A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
01/04/2007WO2006093911A3 Thiazolylmethyl and oxazolylmethyl heteroaryl derivatives
01/04/2007WO2006085978A3 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression
01/04/2007WO2006020598A3 Amido compounds and their use as pharmaceuticals
01/04/2007WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors
01/04/2007WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
01/04/2007WO2005012297A9 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
01/04/2007US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems
01/04/2007US20070004786 (5S)-2-Amino-5-(1-ethyl-5-propionyl-1H-pyrrol-3-yl)-5-[4-fluoro-3-(2-fluoropyridin-3-yl)phenyl]-3-methyl-3,5-dihydro-4H-imidazol-4-one; to treat Alzheimer's disease, cognitive impairment, Down's Syndrome, senile dementia, cerebral amyloid angiopathy, neurofibrillary tangles, beta -amyloid deposits
01/04/2007US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents
01/04/2007US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
01/04/2007US20070004751 Substituted heterocyclic compounds
01/04/2007US20070004741 N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
01/04/2007US20070004729 Methods and compositions of novel triazine compounds
01/04/2007US20070004722 3-(2-butynyloxy)-5-(pyrrolidin-1-yl)-1,2,4-thiadiazole; compounds can effectively control pests such as insect pests, acarine pests and the like
01/04/2007US20070004713 Therapeutic benimidazole compounds
01/04/2007US20070004712 Salts of novel heterocyclic compounds having antibacterial activity
01/04/2007US20070004677 purinergic receptor antagonists such as N-(2-(2-tert-butylphenoxy)pyridin-3-yl)cinnamamide, used for modulation of platelet reactivity; anticoagulants
01/04/2007US20070003873 High density recording media with modified recording layers of the invention provides better photoelectrical performance; high recording sensitivity and high carrier-to-noise ratio
01/04/2007CA2613162A1 Heterocyclic non-peptide gnrh antagonists
01/04/2007CA2612969A1 Oxazolidinone derivatives and use thereof as antibiotics
01/04/2007CA2612601A1 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
01/04/2007CA2611953A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
01/04/2007CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/03/2007EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
01/03/2007EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
01/03/2007EP1737881A2 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease
01/03/2007EP1737852A2 Polycyclic pyridines as potassium ion channel modulators
01/03/2007EP1737850A2 A novel process for the preparation of linezolid and related compounds
01/03/2007EP1737845A2 Disalt inhibitors of il-12 production
01/03/2007EP1737844A2 Bicyclic anthranilamide derivatives useful as insecticides
01/03/2007EP1737843A1 Inhibitors of akt activity
01/03/2007EP1737841A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
01/03/2007EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
01/03/2007EP1737838A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
01/03/2007EP1737831A1 Neurologically-active compounds
01/03/2007EP1737818A2 Methods for the preparation of stereoisomerically enriched amines
01/03/2007EP1737463A1 Pyrimidines with tie2 (tek) activity
01/03/2007EP1737462A1 Pyrimidines with tie2 (tek) activity
01/03/2007EP1737451A2 Monocyclic heterocycles as kinase inhibitors
01/03/2007EP1737450A1 Aqueous composition comprising thiazole derivative
01/03/2007EP1569930B1 Indol derivatives and their use as 5-ht ligands
01/03/2007EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
01/03/2007EP1506203B1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
01/03/2007EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
01/03/2007EP1389617B1 Heterocyclic compound and antitumor agent containing the same as active ingredient
01/03/2007EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
01/03/2007CN1890236A Novel thiazole derivates
01/03/2007CN1890234A Novel quinoline derivatives
01/03/2007CN1890228A Alpha-amino acid derivatives and use thereof as medicines
01/03/2007CN1890226A Oxazole derivatives of tetracyclines
01/03/2007CN1890223A Capsaicin receptor agonists
01/03/2007CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease
01/03/2007CN1890214A Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1
01/03/2007CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
01/03/2007CN1889951A Substituted benzazoles and methods of their use as inhibitors of RAF kinase
01/03/2007CN1887874A Ornidazole derivative and its prepn and use
01/03/2007CN1293076C Activator for peroxisome proliferator-activated receptor delta
01/03/2007CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
01/03/2007CN1293059C New Carboxglic acid derivative, its preparation and application
01/03/2007CN1293058C O-cyclopropyl-carboxanilides and their use as fungicides
01/03/2007CN1293057C Ethylenediamine derivatives
01/03/2007CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
01/03/2007CN1293042C Aromatic amino acid derivates and medicinal compositions
01/02/2007US7157595 In presence of alpha-olefin; ester hydrolysis
01/02/2007US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
01/02/2007US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents
01/02/2007US7157577 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors
01/02/2007US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
01/02/2007US7157489 HIV protease inhibitors
01/02/2007US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders
01/02/2007US7157487 Vla-4 inhibitors
01/02/2007US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection
01/02/2007US7157478 For therapy of Alzheimer's disease
01/02/2007US7157476 Aminofurazan compounds useful as protein kinase inhibitors
01/02/2007US7157473 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV)
01/02/2007US7157470 For use as anticoagulant agents for therapy of thromboembolic disorders
01/02/2007US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
01/02/2007US7157468 Pyrazole derivatives
01/02/2007US7157466 Quinazoline ditosylate salt compounds
01/02/2007US7157462 Therapeutic agents useful for treating pain
01/02/2007US7157457 Compounds useful in the treatment of inflammatory diseases
01/02/2007US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer
01/02/2007US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2007CA2153419C Novel taxoids, preparation thereof and pharmaceutical compositions containing same
12/2006
12/28/2006WO2006138259A2 Chemokine receptor binding compounds
12/28/2006WO2006137658A1 New substituted 1,3-thiazole derivatives or pharmaceutically acceptable salts thereof having immunosuppression and inflammation inhibitory acitivity, intermediate compounds or pharmaceutically acceptable salts thereof, a process for the preparation thereof, and pharmaceutical composition comprising the same
12/28/2006WO2006137527A1 Thiazole derivative